Literature DB >> 30963815

Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer data.

Sandrine Boulet1, Moreno Ursino1, Peter Thall2, Bruno Landi3, Céline Lepère3, Simon Pernot3, Anita Burgun1,4, Julien Taieb3, Aziz Zaanan3, Sarah Zohar1, Anne-Sophie Jannot1,4.   

Abstract

BACKGROUND: Building tools to support personalized medicine needs to model medical decision-making. For this purpose, both expert and real world data provide a rich source of information. Currently, machine learning techniques are developing to select relevant variables for decision-making. Rather than using data-driven analysis alone, eliciting prior information from physicians related to their medical decision-making processes can be useful in variable selection. Our framework is electronic health records data on repeated dose adjustment of Irinotecan for the treatment of metastatic colorectal cancer. We propose a method that incorporates elicited expert weights associated with variables involved in dose reduction decisions into the Stochastic Search Variable Selection (SSVS), a Bayesian variable selection method, by using a power prior.
METHODS: Clinician experts were first asked to provide numerical clinical relevance weights to express their beliefs about the importance of each variable in their medical decision making. Then, we modeled the link between repeated dose reduction, patient characteristics, and toxicities by assuming a logistic mixed-effects model. Simulated data were generated based on the elicited weights and combined with the observed dose reduction data via a power prior. We compared the Bayesian power prior-based SSVS performance to the usual SSVS in our case study, including a sensitivity analysis using the power prior parameter.
RESULTS: The selected variables differ when using only expert knowledge, only the usual SSVS, or combining both. Our method enables one to select rare variables that may be missed using only the observed data and to discard variables that appear to be relevant based on the data but not relevant from the expert perspective.
CONCLUSION: We introduce an innovative Bayesian variable selection method that adaptively combines elicited expert information and real world data. The method selects a set of variables relevant to model medical decision process.

Entities:  

Keywords:  Bayesian variable selection; clinical relevance weights elicitation; electronic health record; power prior method; repeated measures

Mesh:

Substances:

Year:  2019        PMID: 30963815      PMCID: PMC9133490          DOI: 10.1177/0962280219841082

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   2.494


  15 in total

1.  Simultaneous regression shrinkage, variable selection, and supervised clustering of predictors with OSCAR.

Authors:  Howard D Bondell; Brian J Reich
Journal:  Biometrics       Date:  2007-06-30       Impact factor: 2.571

2.  Dose-finding and pharmacokinetic study to optimize the dosing of irinotecan according to the UGT1A1 genotype of patients with cancer.

Authors:  Federico Innocenti; Richard L Schilsky; Jacqueline Ramírez; Linda Janisch; Samir Undevia; Larry K House; Soma Das; Kehua Wu; Michelle Turcich; Robert Marsh; Theodore Karrison; Michael L Maitland; Ravi Salgia; Mark J Ratain
Journal:  J Clin Oncol       Date:  2014-06-23       Impact factor: 44.544

3.  Semantics derived automatically from language corpora contain human-like biases.

Authors:  Aylin Caliskan; Joanna J Bryson; Arvind Narayanan
Journal:  Science       Date:  2017-04-14       Impact factor: 47.728

4.  Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials.

Authors:  J C-H Yang; L V Sequist; C Zhou; M Schuler; S L Geater; T Mok; C-P Hu; N Yamamoto; J Feng; K O'Byrne; S Lu; V Hirsh; Y Huang; M Sebastian; I Okamoto; N Dickgreber; R Shah; A Märten; D Massey; S Wind; Y-L Wu
Journal:  Ann Oncol       Date:  2016-09-06       Impact factor: 32.976

5.  Real-world chemotherapy treatment patterns in metastatic non-small cell lung cancer: Are patients undertreated?

Authors:  Adrian G Sacher; Lisa W Le; Anthea Lau; Craig C Earle; Natasha B Leighl
Journal:  Cancer       Date:  2015-04-17       Impact factor: 6.860

Review 6.  Risk factors determining chemotherapeutic toxicity in patients with advanced colorectal cancer.

Authors:  F G Jansman; D T Sleijfer; J L Coenen; J C De Graaf; J R Brouwers
Journal:  Drug Saf       Date:  2000-10       Impact factor: 5.606

7.  Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study.

Authors:  Gertraud Stocker; Ulrich T Hacker; Frédéric Fiteni; Jestinah John Mahachie; Arnaud D Roth; Eric Van Cutsem; Marc Peeters; Florian Lordick; Murielle Mauer
Journal:  Eur J Cancer       Date:  2018-06-15       Impact factor: 9.162

8.  Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis.

Authors:  Laura Visa; Paula Jiménez-Fonseca; Elena Asensio Martínez; Raquel Hernández; Ana Custodio; Manuel Garrido; Antonio Viudez; Elvira Buxo; Ignacio Echavarria; Juana María Cano; Ismael Macias; Montserrat Mangas; Eva Martínez de Castro; Teresa García; Felipe Álvarez Manceñido; Ana Fernández Montes; Aitor Azkarate; Federico Longo; Asunción Díaz Serrano; Carlos López; Alicia Hurtado; Paula Cerdá; Raquel Serrano; Aitziber Gil-Negrete; Alfonso Martín Carnicero; Paola Pimentel; Avinash Ramchandani; Alberto Carmona-Bayonas
Journal:  J Geriatr Oncol       Date:  2017-12-11       Impact factor: 3.599

9.  An informatics research agenda to support precision medicine: seven key areas.

Authors:  Jessica D Tenenbaum; Paul Avillach; Marge Benham-Hutchins; Matthew K Breitenstein; Erin L Crowgey; Mark A Hoffman; Xia Jiang; Subha Madhavan; John E Mattison; Radhakrishnan Nagarajan; Bisakha Ray; Dmitriy Shin; Shyam Visweswaran; Zhongming Zhao; Robert R Freimuth
Journal:  J Am Med Inform Assoc       Date:  2016-04-23       Impact factor: 4.497

10.  Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience.

Authors:  Bhavana Bhatnagar; Steven Gilmore; Olga Goloubeva; Colleen Pelser; Michelle Medeiros; Saranya Chumsri; Katherine Tkaczuk; Martin Edelman; Ting Bao
Journal:  Springerplus       Date:  2014-07-16
View more
  3 in total

1.  Clinician involvement in research on machine learning-based predictive clinical decision support for the hospital setting: A scoping review.

Authors:  Jessica M Schwartz; Amanda J Moy; Sarah C Rossetti; Noémie Elhadad; Kenrick D Cato
Journal:  J Am Med Inform Assoc       Date:  2021-03-01       Impact factor: 4.497

Review 2.  Research and Application of Artificial Intelligence Based on Electronic Health Records of Patients With Cancer: Systematic Review.

Authors:  Xinyu Yang; Dongmei Mu; Hao Peng; Hua Li; Ying Wang; Ping Wang; Yue Wang; Siqi Han
Journal:  JMIR Med Inform       Date:  2022-04-20

3.  What Do You Think? Using Expert Opinion to Improve Predictions of Response Propensity Under a Bayesian Framework.

Authors:  Stephanie Coffey; Brady T West; James Wagner; Michael R Elliott
Journal:  Methoden Daten Anal       Date:  2020
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.